Home | Ge-Bu

Visible and invisible influence of the medical devices industry in hospitals

Sanne van der Heijden
Nr 10|2019 (53)|Page 97-100|New|doi: 10.35351/gebu.2019.10.19

It is well-known that technicians employed by commercial companies are involved in the maintenance of working on medical devices in hospitals. Unclear, however, is what exactly they do, what their ...

In short Read article

Is an insulin pump not superior to injections for children with newly discovered diab

Tjalling W. de Vries
Nr 10|2019 (53)|Page 93-96|New|doi: 10.35351/gebu.2019.10.18

There is currently a trend to start the treatment of children with type 1 diabetes mellitus with a subcutaneous insulin pump, rather than with the conventional insulin injections. No clear evidenc ...

In short Read article

New product form: Calcipotriol/betamethasone aerosol foam for psoriasis

Leo M.L. Stolk
Nr 9|2019 (53)|Page 86-90|New|doi: 10.35351/gebu.2019.9.17

Calcipotriol/betamethasone aerosol foam 0.05mg/g and 0.5 mg/g (Enstilar®) were registered in 2016 for the ‘local treatment of psoriasis vulgaris in adults’. The combination of calcipotriol and bet ...

In short Read article

Treatment of actinic keratosis with 5-FU cream

Anton J.F.A. Kerst, Hein J.E.M. Janssens
Nr 9|2019 (53)|Page 81-85|New|doi: 10.35351/gebu.2019.9.16

Actinic keratosis is a skin disorder which occurs in about 30% of persons aged over 50 years (more commonly among men). The main causative factor is exposure to sunlight. If not treated, there is ...

In short Read article

PrEP effectively reduces risk of HIV infection, provided it is used with care

Sanne van der Heijden
Nr 8|2019 (53)|Page 74-78|Main article|doi: 10.35351/gebu.2019.8.15

The Dutch Minister for Medical Care and Sports has recently announced that the financial resources for care associated with so-called pre-exposure prophylaxis (PrEP) will be allocated to Dutch reg ...

In short Read article

Opioids for chronic pain: scarcely any added value

Anton J.F.A. Kerst. Hein J.E.M. Janssens
Nr 8|2019 (53)|Page 69-73|Main article|doi: 10.35351/gebu.2019.8.14

The unmistakable increase in the number of prescriptions for opioids (with their associated risks of addiction and adverse effects) should be a subject for debate. There is, or at least appears to ...

In short Read article

Health apps for natural contraception: old wine in new bottles

Hajo I. Wildschut
Nr 6-7|2019 (53)|Page 61-65|Main article|doi: 10.35351/gebu.2019.6-7.12

Apps such as NaturalCycles® are being used by many women around the world as a natural, non-medical method of contraception. These apps are medical devices, which in principle have to meet the sam ...

In short Read article

Off-label use of mirtazapine to treat insomnia

Marielle A.E. Nieuwhof
Nr 6-7|2019 (53)|Page 66-68|New|doi: 10.35351/gebu.2019.6-7.13

The antidepressant mirtazapine (Remeron®) is increasingly used by patients suffering from insomnia. However, this usage is not based on evidence of effectivity from randomised studies. At best, th ...

In short Read article

Search

Recent articles

Visible and invisible influence of the medical devices industry in hospitals

Is an insulin pump not superior to injections for children with newly discovered diab

New product form: Calcipotriol/betamethasone aerosol foam for psoriasis

Treatment of actinic keratosis with 5-FU cream

PrEP effectively reduces risk of HIV infection, provided it is used with care

Opioids for chronic pain: scarcely any added value

Health apps for natural contraception: old wine in new bottles

Off-label use of mirtazapine to treat insomnia